These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21645380)

  • 21. Susceptibility of anaerobic bacteria to ten antimicrobial agents.
    Appelbaum PC; Chatterton SA
    Antimicrob Agents Chemother; 1978 Sep; 14(3):371-6. PubMed ID: 708014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of eumycetoma and actinomycetoma.
    Welsh O; Salinas MC; Rodríguez MA
    Curr Top Med Mycol; 1995; 6():47-71. PubMed ID: 8724241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actinomycetoma and advances in its treatment.
    Welsh O; Vera-Cabrera L; Welsh E; Salinas MC
    Clin Dermatol; 2012; 30(4):372-81. PubMed ID: 22682184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance patterns of Salmonella isolates of equine origin from India.
    Singh BR; Jyoti J; Chandra M; Babu N; Sharma G
    J Infect Dev Ctries; 2009 Mar; 3(2):141-7. PubMed ID: 19755745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial responses of Yersinia enterocolitica isolates in comparison to other commonly encountered bacteria that causes diarrhoea.
    Andualem B; Geyid A
    East Afr Med J; 2005 May; 82(5):241-6. PubMed ID: 16119753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actinomycetoma Caused by Actinomadura mexicana, A Neglected Entity in the Caribbean.
    Bessis S; Noussair L; Rodriguez-Nava V; Jousset C; Duran C; Beresteanu A; Matt M; Davido B; Carlier R; Bergeron E; Fournier PE; Herrmann JL; Dinh A
    Emerg Infect Dis; 2020 Feb; 26(2):379-380. PubMed ID: 31961313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mycetoma: 130 cases].
    Dieng MT; Sy MH; Diop BM; Niang SO; Ndiaye B
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):16-9. PubMed ID: 12605151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro antimicrobial susceptibility of Neisseria gonorrhoeae in New Zealand.
    Green MJ
    Br J Vener Dis; 1978 Oct; 54(5):316-21. PubMed ID: 101276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actinomycetoma by
    Bonifaz A; Tirado-Sánchez A; Vázquez-González D; Fierro-Arias L; Araiza J; González GM
    J Dermatolog Treat; 2022 Mar; 33(2):954-958. PubMed ID: 32643472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study.
    Khatri ML; Al-Halali HM; Fouad Khalid M; Saif SA; Vyas MC
    Int J Dermatol; 2002 Sep; 41(9):586-93. PubMed ID: 12358829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Draft genome sequence of the human pathogen Streptomyces somaliensis, a significant cause of actinomycetoma.
    Kirby R; Sangal V; Tucker NP; Zakrzewska-Czerwinska J; Wierzbicka K; Herron PR; Chu CJ; Chandra G; Fahal AH; Goodfellow M; Hoskisson PA
    J Bacteriol; 2012 Jul; 194(13):3544-5. PubMed ID: 22689234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycetomas caused by Streptomyces pelletieri in Madras, India.
    Taralakshmi VV; Pankajalakshmi VV; Kamalakannan R; Annamalai R; Shetty BM; Subramanian S; Shanmugasundaram TK
    Arch Dermatol; 1978 Feb; 114(2):204-6. PubMed ID: 629546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of antibiotics against Streptomyces somaliensis isolates in vitro.
    Nasher MA; Hay RJ
    J Antimicrob Chemother; 1998 Feb; 41(2):281-4. PubMed ID: 9533473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Neisseria gonorrhoeae to seven antibiotics in vitro.
    Robson HG; Salit IE
    Can Med Assoc J; 1972 Nov; 107(10):959-62. PubMed ID: 4628259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)].
    Okada J; Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Dec; 28(6):727-39. PubMed ID: 1042183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid: a safer and effective substitute to aminoglycoside in the treatment of actinomycetoma by Nocardia species.
    Chhabra N; Sri P; Ganguly S
    Int J Dermatol; 2023 Sep; 62(9):1160-1163. PubMed ID: 37366290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinomycetoma laboratory-based diagnosis: a mini-review.
    Siddig EE; van de Sande WWJ; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):355-363. PubMed ID: 33449118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mycetoma and their treatment].
    Develoux M
    J Mycol Med; 2016 Jun; 26(2):77-85. PubMed ID: 27260344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.